We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Genetic Structure Determined for Pathogenic Spirochete

By LabMedica International staff writers
Posted on 27 Oct 2010
The complete genetic structures of 13 strains of the bacteria that cause Lyme disease have been resolved. More...


Lyme disease is the most frequent tick-borne disease in North America and Europe. There are multiple variants of Borrelia burgdorferi, the causative agent, but questions remain about how their variation correlates with different clinical manifestations.

A single genome sequence is not sufficient to understand the relationship between genotypic and geographic variation and disease phenotype. In a collaborative study carried out at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, (UMDNJ; Newark, NJ, USA), the whole genome sequence of 13 different isolates that span the range of natural variation has been determined. The strains were isolated from human and other natural sources.

New insights into Lyme disease are needed. While the bacterium that causes the disease has been known for 27 years, there still is no vaccine for humans available. The authors believe that their sequence information will help investigators design improved diagnostic tests and vaccines. Efficient tests are needed because the telltale rash on the skin does not always appear in infected patients. Cultures, which work well for many other bacteria, take too long to be of immediate use for Lyme bacteria. Serological and DNA assays have proven to be unsatisfactory. Therefore, these sequences should allow improved understanding of pathogenesis and provide a foundation for novel detection, diagnosis, and prevention strategies.

These new discoveries may accelerate research efforts to diagnose, prevent, and treat the disease, which can affect the nervous system, heart, skin, and joints. The occurrence of the disease has grown dramatically over the past ten years in the U.S. and Europe. There were nearly 30,000 new cases of Lyme disease reported in the U.S. in 2009, and cases have increased by 90% in the U.K.

Steven E. Schutzer, M.D., the senior author of the study, said, "A driving force for doing this project was the observation that certain forms of the bacteria can be more invasive than others. We wanted to find out why and how to identify this property".

The study was published in October 2010 in the Journal of Bacteriology.

Related Links:

University of Medicine and Dentistry of New Jersey





Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.